Heart Transplantation Therapeutics Market by Product and Geography - Forecast and Analysis 2020-2024

The global heart transplantation therapeutics market size has the potential to grow by USD 94.37 million during 2020-2024, and the market’s growth momentum will accelerate throughout the forecast period.

This report provides a detailed analysis of the market by geography (Asia, Europe, North America, and ROW) and product (immunosuppressants and supplementary medications). Also, the report analyzes the market’s competitive landscape and offers information on several market vendors, including AbbVie Inc., Astellas Pharma Inc., Cadila Healthcare Ltd., F. Hoffmann-La Roche Ltd., Mylan NV, Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Veloxis Pharmaceuticals A/S.

Market Overview

Browse TOC and LoE with selected illustrations and example pages of heart transplantation therapeutics market

Request a FREE sample now!

Market Competitive Analysis

The market is fragmented, and the degree of fragmentation will remain the same during the forecast period. The key players in the market are focusing on various inorganic growth strategies such as strategic alliances and collaborations to expand the geographical reach and gain major market shares and revenue. Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Veloxis Pharmaceuticals A/S. are a few of the major market participants. Although the accelerating growth momentum will offer immense business opportunities, long-term complications associated with heart transplantation will challenge the growth of the market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

To help clients improve their market positions, this heart transplantation therapeutics market forecast report provides a detailed analysis of the market leaders and offers information on the competencies and capacities of these companies. The report also covers details on the market’s competitive landscape and offers information on the products offered by various companies. Moreover, this heart transplantation therapeutics market analysis report provides information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of future growth opportunities.

This report provides information on the production, sustainability, and prospects of several leading heart transplantation therapeutics companies, including:

• AbbVie Inc.
• Astellas Pharma, Inc.
• Cadila Healthcare Ltd. 
• F. Hoffmann-La Roche Ltd.
• Mylan NV
• Novartis AG
• Pfizer Inc.
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.
• Veloxis Pharmaceuticals A/S

Heart Transplantation Therapeutics Market: Segmentation by Region

For more insights on the heart transplantation therapeutics market share of various regions Request for a FREE sample now!

North America was the largest market for heart transplantation therapeutics in 2019, and the region will continue to offer maximum growth opportunities to market vendors during the forecast period. The increasing sales of immunosuppressants, the prevalence of the risks associated with heart transplantation, and incidence rate of cardiovascular diseases will significantly influence the heart transplantation therapeutics market growth in the region.

Over 55% of the market’s growth will originate from North America during the forecast period. The US, Canada, and Mexico are the key markets of heart transplantation therapeutics in North America. Market growth in this region will be faster than the growth of the market in Europe and ROW.

Heart Transplantation Therapeutics Market: Segmentation by Product

Request for a FREE sample and Get more information on the market contribution of various products

Immunosuppressants are drugs that suppress the body’s ability to attack a newly transplanted organ and aid in keeping it healthy and free from damage. The mechanism of actions (MoA) of these drugs to treat and prevent organ rejection has designated them as a mainstay therapeutic option for heart transplant recipients. The market segment includes various branded and generic drugs such as cyclosporine, tacrolimus, and sirolimus. Among these drugs, tacrolimus is often used in patients undergoing organ transplantation, including heart transplantation.

The market growth by the immunosuppressants segment will be faster than the growth of the market by the supplementary medications segment. This report provides an accurate prediction of the contribution of all the segments to the growth of the heart transplantation therapeutics market size.

Heart Transplantation Therapeutics Market: Key Drivers and Trends

The growing advances in surgical techniques have increased patient adherence to surgeries such as organ transplantation. However, graft rejection is one of the major challenges associated with organ transplantation, which is intensified in heart transplantation. Since heart transplant rejection can be chronic, immunosuppressants are prescribed to the patients to reduce organ rejection chances. Immunosuppressants intended for maintenance regimens are used throughout patients’ lives.

Furthermore, vendors are offering customized dosage forms of immunosuppressants to healthcare practitioners based on individuals’ requirements. Therefore, the increasing number of heart transplantation and risks associated with transplant rejection will increase the demand for immunosuppressants. As a result, the heart transplantation therapeutics market growth will be substantial over the forecast period.

• The number of heart transplantation is substantially higher than other transplantation procedures owing to the high prevalence of risk factors for heart impairment.
• Revolutionary achievements in the field of regenerative therapies have led researchers to discover possible regenerative medicinal applications in organ transplantation.
• The introduction of novel approaches for heart regeneration and transplantation is one of the key heart transplantation therapeutics market trends.
• The market is recording rapid development in the field of regenerative therapies such as cell therapy, gene therapy, and tissue engineering, which involve the development of heart or other organs.
• Organ printing is a new technology, which is a layer-by-layer additive robotic bio-fabrication of 3D functional living macro tissues and organ constructs using tissue spheroids as building blocks.
• During 2020-2024, the market will grow at a CAGR of almost 3%.

Request for a FREE sample now!

Heart Transplantation Therapeutics Market: Key Highlights of the Report for the Forecast Period 2020-2024

• CAGR of the market during the forecast period 2020-2024
• Detailed information on factors that will accelerate the heart transplantation therapeutics market growth during the next five years
• Precise estimation of the global heart transplantation therapeutics market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the heart transplantation therapeutics industry across Asia, Europe, North America, and ROW
• A thorough analysis of the market’s competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of heart transplantation therapeutics vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch